Qi Hong

USPTO Granted Patents = 20 (Patent Applications = 17)

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 12 (Patent Applications = 6)

Average Co-Inventor Count = 4.5

ph-index = 7

Forward Citations = 636(Granted Patents)

Location History:

Whippany, NJ (US) (2013 - 2020)
Sharon, MA (US) (2006 - 2024)

Company Filing History:

Purdue Pharmaceuticals L.p.

The P.f. Laboratories, Inc.

7. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2006-2024

Loading Chart...

20 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12060361 - Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone (2024-08-13),

2. 11384091 - Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone (2022-07-12),

3. 11236098 - Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone (2022-02-01),

4. 10869819 - Compositions having a plurality of discrete emulsions (2020-12-22),

5. 10696684 - Process for preparing oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone (2020-06-30),

6. 10689389 - Process for preparing oxycodone compositions (2020-06-23),

7. 10407434 - Process for preparing oxycodone compositions (2019-09-10),

8. 10259819 - Process for preparing oxycodone compositions (2019-04-16),

9. 9777011 - Process for preparing oxycodone compositions (2017-10-03),

10. 9522919 - Oxycodone compositions (2016-12-20),

11. 9073933 - Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone (2015-07-07),

12. 9023327 - DICKKOPF-1 expression modulating compositions and uses thereof (2015-05-05),

13. 8822687 - 8a,14-dihydroxy-7,8-dihydrocodeinone (2014-09-02),

14. 8613911 - Compositions having a plurality of discrete emulsions (2013-12-24),

15. 8575106 - Cosmetic uses of modified stressed yeast extracts and related compositions (2013-11-05),

Title: The Innovative Journey of Inventor Qi Hong

Introduction

Qi Hong, an accomplished inventor based in Sharon, MA, has made significant contributions to the field of pharmaceutical chemistry. With a remarkable portfolio of 16 patents, her work has notably advanced the preparation processes of oxycodone hydrochloride, enhancing its safety and efficacy.

Latest Patents

Among her latest innovations, Qi Hong has developed a process for preparing oxycodone hydrochloride compositions that contain less than 25 parts per million (ppm) of 14-hydroxycodeinone. This invention addresses critical quality control issues, ensuring that the pharmaceutical product meets stringent regulatory standards and is safer for consumer use.

Career Highlights

Throughout her career, Qi has worked with esteemed companies such as Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. Her expertise in pharmaceutical processes and drug formulation has been instrumental in driving innovation within these organizations, solidifying her reputation as a leading inventor in her field.

Collaborations

Qi has collaborated with prominent professionals in her industry, including colleagues such as Lonn S. Rider and Robert Chapman. These partnerships have fostered a collaborative spirit in her projects, further contributing to her successful innovations in drug development.

Conclusion

With her extensive knowledge, innovative spirit, and commitment to improving pharmaceutical formulations, Qi Hong continues to be a vital contributor to the field. Her patents not only reflect her ingenuity but also her dedication to advancing healthcare through safer and more effective medication solutions.

This text is generated by artificial intelligence and may not be accurate.